ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет Архив журнала 2005 год № 3

Клинические проявления мутаций рецептора ТТГ: патология рецептора ТТГ

Thyroid international 3 – 2005
Дэвид Калебиро, Лука Перзани, Паоло Бэк-Пэкос
Institute of Endocrine Sciences, University of Milan, Fondazione Ospedale Maggiore IRCCS and Istituto Auxologico Italiano IRCCS, Milan, Italy
Русский перевод д.м.н. Фадеева В.В.1



ЛИТЕРАТУРА

  1. Parmentier M, Libert F, Maenhaut C, et al. Molecular cloning of the thyrotropin receptor. Science 1989; 246: 1620-1622. ^
  2. Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for human thyrotropin receptor. Biochem Biophys Res Commun 1989; 165:1184 –1190. ^
  3. Libert F, Lefort A, Gerard C, et al. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun 1989; 165:1250 –1255. ^
  4. Misrahi M, Loosfelt H, Atger M, et al. Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 1990; 166:394-403. ^
  5. Hampel R, Kulberg T, Klein K, et al. Goiter incidence in Germany is greater than previously suspected. Med Klin 1995; 90:324–329. ^
  6. Dumont JE, Jauniaux JC, Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 1989;14:67-71. ^
  7. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992; 72:667-697. ^
  8. Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340:692-696. ^
  9. Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365:649-651. ^
  10. Parma J, Duprez L, Van Sande J, et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997; 82:2695-2701. ^
  11. Fuhrer D, Holzapfel HP, Wonerow P, et al. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 1997; 82:3885-3891. ^
  12. Paschke R, Tonacchera M, Van Sande J, et al. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 1994; 79:1785-1789. ^
  13. Parma J, Van Sande J, Swillens S, et al. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 1995; 9:725-733. ^
  14. Porcellini A, Ciullo I, Laviola L, et al. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 1994; 79:657-661. ^
  15. Porcellini A, Ciullo I, Pannain S, et al. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signaling in thyroid hyperfunctioning adenomas. Oncogene 1995; 11:1089-1093. ^
  16. Russo D, Arturi F, Suarez HG, et al. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1996; 81:1548-1551. ^
  17. Duprez L, Parma J, Costagliola S, et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 1997; 409:469-474. ^
  18. Holzapfel HP, Wonerow P, von Petrykowski W, et al. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocr Metab 1997; 82: 3879 - 3884. ^
  19. Tonacchera M, Chiovato L, Pinchera A, et al. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab 1998; 83:492-498. ^
  20. Trulzsch B, Krohn K, Wonerow P, et al. Detection of thyroidstimulating hormone receptor and Gsalpha mutation in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 2001; 78:684-691. ^
  21. Trulzsch B, Krohn K, Wonerow P, Paschke R. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 1999; 27:266-268 ^
  22. Georgopoulos NA, Sykiotis GP, Sgourou A, et al. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-offunction mutations in the thyrotropin signaling pathway. Eur J Endocrinol 2003; 149:287-292. ^
  23. Gruters A, Schoneberg T, Biebermann H, et al. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocr Metab 1998; 83: 1431-1436. ^
  24. Nakabayashi K, Kudo M, Kobilka B, et al. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J Biol Chem 2000; 275:30264-30271. ^
  25. Zhang ML, Sugawa H, Kosugi S, Mori T. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Commun 1995; 211:205-210. ^
  26. Van Sande J, Massart C, Costagliola S, et al. Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 1996; 119: 161-168. ^
  27. Zhang M, Tong KP, Fremont V, et al. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 2000; 141:3514-3517. ^
  28. Kosugi S, Shenker A, Mori T. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett 1994; 356:291-294. ^
  29. Spambalg D, Sharifi N, Elisei R, et al. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab 1996; 81:3898-3901. ^
  30. Fuhrer D, Wonerow P, Willgerodt H, Paschke R. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 1997; 82:4234-4238. ^
  31. Lin Z, Shenker A, Pearlstein R. A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. Protein Eng 1997; 10:501-510. ^
  32. Neumann S, Krause G, Chey S, Paschke R. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Mol Endocrinol 2001; 15:1294-1305. ^
  33. Russo D, Arturi F, Wicker R, et al. Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1995; 80:1347-351. ^
  34. Persani L, Lania A, Alberti L, et al. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J Clin Endocrinol Metab 2000; 85:2872-2878. ^
  35. Russo D, Arturi F, Schlumberger M, et al. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 1995; 11:1907-1911. ^
  36. Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 1997; 82: 735 - 738. ^
  37. Baloch Z, Livolsi VA. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 1997; 82:3906-3908. ^
  38. Russo D, Wong MG, Costante G, et al. A Val 677 activating mutation of the thyrotropin receptor in a Hurthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid 1999; 9:13-17. ^
  39. Mircescu H, Parma J, Huot C, et al. Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J Pediatr 2000; 137:585-587. ^
  40. Camacho P, Gordon D, Chiefari E, et al. Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid 2000; 10:1009-1012. ^
  41. Fuhrer D, Tannapfel A, Sabri O, et al. Two somatic TSH receptor mutations in a patient with toxic metastasizing follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer 2003; 10: 591-600. ^
  42. Calebiro D, Di Pasquale E, de Filippis T, et al. Identificazione di una mutazione del gene del recettore del TSH in un carcinoma differenziato della tiroide. XX Giornate Italiane della Tiroide, Pisa 5-7 dicembre 2002 (P38). ^
  43. Puxeddu E, Fagin JA. Genetic markers in thyroid neoplasia. Endocrinol Metab Clin North Am 2001;30:493-513. ^
  44. Kopp P, van Sande J, Parma J, et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropinreceptor gene. N Engl J Med 1995; 332:150-154. ^
  45. De Roux N, Polak M, Couet J, et al. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 1996; 81:2023–2026. ^
  46. Schwab KO, Sohlemann P, Gerlich M, et al. Mutations of the TSH receptor as cause of congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 1996; 104: 124 - 128. ^
  47. Duprez L, Parma J, Van Sande J, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994; 7: 396 – 401. ^
  48. Tonacchera M, Van Sande J, Cetani F, et al. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 1996; 81:547-554. ^
  49. Alberti L, Proverbio MC, Costagliola S, et al. A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 2001; 145:249-254. ^
  50. Harada A, Hershman JM, Reed AW, et al. Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 1979; 48:793-797. ^
  51. Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev 1993; 14:194-202. ^
  52. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18:404-433. ^
  53. Grossmann M, Weintraub BD, Szkudlinski MW. Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr Rev 1997; 18:476-501. ^
  54. Rodien P, Bremont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998; 339:1823-1826. ^
  55. Smits G, Govaerts C, Nubourgh I, et al. Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Mol Endocrinol 2002; 16:722-735. ^
  56. Stanbury JB, Rocmans P, Buhler UK, Ochi Y. Congenital hypothyroidism with impaired thyroid response to thyrotropin. N Engl J Med 1968; 21:1132-1136. ^
  57. Job JC, Canlorbe P, Thomassin N, and Vassal J. Infantile hypothyroidism with early onset, thyroid gland in place, weak fixation of radio-iodine and defective response to thyreostimulin. Ann Endocrinol 1969; 30:696-701^
  58. Medeiros-Neto GA, Knobel M, Bronstein MD. Impaired cAMP response to thyrotropin in congenital hypothyroidism with thyroglobulin deficiency. Acta Endocrinol 1979; 92:62-68. ^
  59. Codaccioni JL, Carayon P, Michel-Bechet M, et al. Congenital hypothyroidism associated with thyrotropin unresponsiveness and thyroid cell membrane alterations. J Clin Endocrinol Metab 1980; 50:932-937. ^
  60. Aarseth HP, Haug E, Raknerud N, Frey, HM. TSH unresponsiveness, a case report. Acta Endocrinol 1983; 102:358-366. ^
  61. Takamatsu J, Nishikawa M, Horimoto M, Ohsawa N. Familial unresponsiveness to thyrotropin by autosomal recessive inheritance. J Clin Endocrinol Metab 1993; 77:1569-1573. ^
  62. Stein SA, Oates EL, Hall CR, et al. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 1994; 8:129-138. ^
  63. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995; 332:155–160. ^
  64. De Roux N, Misrahi M, Brauner R, et al. Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab 1996; 81:4229–4235. ^
  65. Clifton-Bligh RJ, Gregory JW, Ludgate M, et al. Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab 1997; 82:1094 –1100. ^
  66. Abramowicz MJ, Duprez L, Parma J, et al. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Inves 1997; 99:3018-3024. ^
  67. Biebermann H, Schoneberg T, Krude H, et al. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 1997; 82: 3471 - 3480. ^
  68. Gagne N, Parma J, Deal C, et al. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab 1998; 83:1771-1775. ^
  69. Tiosano D, Pannain S, Vassart G, et al. The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 1999; 9:887-894. ^
  70. Tonacchera M, Agretti P, Pinchera A, et al. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. J Clin Endocrinol Metab 2000; 85:1001-1008. ^
  71. Russo D, Betterle C, Arturi F, et al. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. J Clin Endocrinol Metab 2000; 85: 4238-4242. ^
  72. Nagashima T, Murakami M, Onigata K, et al. Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin. Thyroid 2001; 11:551-559. ^
  73. Tonacchera M, Agretti P, De Marco G, et al. Thyroid resistance to TSH complicated by autoimmune thyroiditis. J Clin Endocrinol Metab 2001; 86: 4543-4546. ^
  74. Bretones P, Duprez L, Parma J, et al. A familial case of congenital hypothyroidism caused by a homozygous mutation of the thyrotropin receptor gene. Thyroid 2001; 11:977-980. ^
  75. Alberti L, Proverbio MC, Costagliola S, et al. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 2002; 87:2549-2555. ^
  76. Takeshita A, Nagayama Y, Yamashita S, et al. Sequence analysis of the thyrotropin (TSH) receptor gene in congenital primary hypothyroidism associated with TSH unresponsiveness. Thyroid 1994; 4: 255 – 259. ^
  77. Refetoff S, Sunthornthepvarakul T, Gottschalk ME, Hayashi Y. Resistance to thyrotropin and other abnormalities of the thyrotropin receptor. Recent Prog Horm Res 1996; 51:97–122. ^
  78. Xie J, Pannain S, Pohlenz J, et al. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab 1997; 82: 3933 – 3940. ^
  79. Nogueira CR, Nguyen LQ, Coelho-Neto JR, et al. Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasia. Thyroid 1999; 9: 523 – 529. ^
  80. Wadsworth HL, Russo D, Nagayama Y, et al. Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol Endocrinol 1992; 6: 394 – 398. ^
  81. Costagliola S, Sunthornthepvarakul T, Migeotte I, et al. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene. Thyroid 1999; 9:995-1000.